No Data
No Data
Express News | Delcath Systems Shares Are Trading Higher After the Company Published a Study by Investigators in the Annals Of Surgical Oncology
Delcath Stock Jumps 15% on Hepzato Kit Study Publication
Delcath Systems Publishes Retrospective Study By Independent Investigators In The Annals Of Surgical Oncology. The Study, Titled "Hepatic And Overall Progression-free Survival After Percutaneous Hepatic Perfusion (PHP) As First-line Or Second-line...
Delcath Systems, Inc. Announces Promising Results From Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
No Data